« Previous
Next »
Titles
- S11 nonclinical safety testing in support of development of pediatric pharmaceuticals1
- S12 nonclinical biodistribution considerations for gene therapy products: guidance for industry1
- S1B(R1) addendum to S1B testing for carcinogenicity of pharmaceuticals: guidance for industry1
- S3A guidance: note for guidance on toxicokinetics : the assessment of systemic exposure in toxicity studies : focus on microsampling : questions and answers1
- S5(R3) detection of reproductive and developmental toxicity for human pharmaceuticals1
- S9 nonclinical evaluation for anticancer pharmaceuticals: questions and answers1
- SAMHSA is missing opportunities to better monitor access to medication-assisted treatment through the buprenorphine waiver program1
- SLE: targets for new therapeutics : a scientific conference1
- SSA disability programs: better metrics and evaluation needed to inform decision-making : testimony before the Subcommittee on Social Security, Committee on Ways and Means, House of Representatives1
- SSA's Compassionate Allowance Initiative: improvements needed to make expedited processing of disability claims more consistent and accurate : report to the Chairman, Subcommittee on Social Security, Committee on Ways and Means, House of Representatives1
- SSA's Compassionate Allowance initiative: actions needed to improve the accuracy and consistency of expedited processing of disability claims : testimony before the Subcommittee on Social Security, Committee on Ways and Means, House of Representatives1
- Safeguards must be strengthened to protect Medicare hospice beneficiaries from harm1
- Safer Sex Intervention evaluation report: short term impact report : teen pregnancy prevention replication study1
- Safer sex intervention: final impact report1
- Safer technologies program for medical devices: guidance for industry and Food and Drug Administration staff1
- Safety and performance based pathway: guidance for industry and Food and Drug Administration1
- Safety considerations for container labels and carton labeling design to minimize medication errors1
- Safety testing of drug metabolites1
- Same surgical procedure exception under 21 CFR 1271.15(b): questions and answers regarding the scope of the exception1
- Sarcomatosis cutis1